Holdings
Atlas Venture Life Science Advisors, LLC
As of Sep 30, 2026, Atlas Venture Life Science Advisors, LLC reported 9 positions worth US$631M. Largest: Kymera Therapeutics, Inc., Disc Medicine, Inc. and Obsidian Therapeutics, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Kymera Therapeutics, Inc. | 2.85M | US$318M | no change | Sep 30, 2026 |
| Disc Medicine, Inc. | 1.38M | US$90.6M | −130K | Sep 30, 2026 |
| Obsidian Therapeutics, Inc. | 4.5M | US$61.8M | new | Sep 30, 2026 |
| Kailera Therapeutics, Inc. | 5.17M | US$59.1M | no change | Sep 30, 2026 |
| Dyne Therapeutics, Inc. | 3.44M | US$55.4M | −3.36M | Sep 30, 2026 |
| Q32 Bio Inc. | 2.72M | US$22.5M | no change | Sep 30, 2026 |
| Sionna Therapeutics, Inc. | 3M | US$15.8M | no change | Sep 30, 2026 |
| Korro Bio, Inc. | 773K | US$7.66M | −190K | Sep 30, 2026 |
| Odyssey Therapeutics, Inc. | 2,692 | US$59,816 | new | Sep 30, 2026 |